Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386454484> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4386454484 endingPage "540" @default.
- W4386454484 startingPage "537" @default.
- W4386454484 abstract "Objective: We aimed to emphasize the possible beneficial effects of intranasal sprays containing mometasone furoate, especially for preventive treatment or supportive treatment in patients with olfactory disorders due to damage to the olfactory area, or for regular use in healthcare workers with a high risk of close contact.
 Methods: Preventive and therapeutic scientific studies are continuing around the world for viral spread and viral damage associated with the Coronavirus disease 2019 (COVID-19) pandemic. We investigated the attachment of the COVID-19 virus in the nose and entry into the body with the crystal structure of the spike and Angiotensin-Converting Enzyme 2 (ACE-2) proteins, a molecular docking study. This scientific study is the first in-silico study to investigate the possible antiviral effects of Mometasone furoate molecules on spike protein and to show the antiviral effect of mometasone furoate on COVID-19.
 Results: We think that nasal sprays containing mometasone furoate can be used prophylactically in patients with COVID-19 infection due to its antiviral effect, and it may be beneficial to use sprays containing mometasone furoate before the symptoms of upper respiratory tract infection begin in patients.
 Conclusions: The role of these molecules in the treatment of acute smell disorders associated with COVID-19 infection and their antiviral effects on coronavirus should be investigated by conducting extensive scientific studies on the subject." @default.
- W4386454484 created "2023-09-06" @default.
- W4386454484 creator A5038690482 @default.
- W4386454484 creator A5072281620 @default.
- W4386454484 creator A5077658455 @default.
- W4386454484 date "2023-09-11" @default.
- W4386454484 modified "2023-10-01" @default.
- W4386454484 title "Nasal Sprays Containing Mometasone Furoate Can Be Used Prophylactically in COVID-19 Infection and Related Smell Disorders" @default.
- W4386454484 cites W1971316257 @default.
- W4386454484 cites W2031292854 @default.
- W4386454484 cites W2036852304 @default.
- W4386454484 cites W2047634451 @default.
- W4386454484 cites W2091652137 @default.
- W4386454484 cites W2132629607 @default.
- W4386454484 cites W2134967712 @default.
- W4386454484 cites W2774416717 @default.
- W4386454484 cites W3012236996 @default.
- W4386454484 cites W3014067025 @default.
- W4386454484 cites W3014781739 @default.
- W4386454484 cites W3022894063 @default.
- W4386454484 cites W3024682365 @default.
- W4386454484 cites W3027133932 @default.
- W4386454484 cites W3028801636 @default.
- W4386454484 cites W3048041170 @default.
- W4386454484 cites W3091935610 @default.
- W4386454484 cites W3118739000 @default.
- W4386454484 cites W3124086690 @default.
- W4386454484 cites W3145623002 @default.
- W4386454484 cites W3168436232 @default.
- W4386454484 cites W3171111496 @default.
- W4386454484 cites W4205336882 @default.
- W4386454484 doi "https://doi.org/10.33808/clinexphealthsci.1094759" @default.
- W4386454484 hasPublicationYear "2023" @default.
- W4386454484 type Work @default.
- W4386454484 citedByCount "0" @default.
- W4386454484 crossrefType "journal-article" @default.
- W4386454484 hasAuthorship W4386454484A5038690482 @default.
- W4386454484 hasAuthorship W4386454484A5072281620 @default.
- W4386454484 hasAuthorship W4386454484A5077658455 @default.
- W4386454484 hasBestOaLocation W43864544842 @default.
- W4386454484 hasConcept C126322002 @default.
- W4386454484 hasConcept C141071460 @default.
- W4386454484 hasConcept C16005928 @default.
- W4386454484 hasConcept C2776804153 @default.
- W4386454484 hasConcept C2778311950 @default.
- W4386454484 hasConcept C2780973058 @default.
- W4386454484 hasConcept C2781348165 @default.
- W4386454484 hasConcept C71924100 @default.
- W4386454484 hasConcept C85663871 @default.
- W4386454484 hasConcept C98274493 @default.
- W4386454484 hasConceptScore W4386454484C126322002 @default.
- W4386454484 hasConceptScore W4386454484C141071460 @default.
- W4386454484 hasConceptScore W4386454484C16005928 @default.
- W4386454484 hasConceptScore W4386454484C2776804153 @default.
- W4386454484 hasConceptScore W4386454484C2778311950 @default.
- W4386454484 hasConceptScore W4386454484C2780973058 @default.
- W4386454484 hasConceptScore W4386454484C2781348165 @default.
- W4386454484 hasConceptScore W4386454484C71924100 @default.
- W4386454484 hasConceptScore W4386454484C85663871 @default.
- W4386454484 hasConceptScore W4386454484C98274493 @default.
- W4386454484 hasIssue "3" @default.
- W4386454484 hasLocation W43864544841 @default.
- W4386454484 hasLocation W43864544842 @default.
- W4386454484 hasOpenAccess W4386454484 @default.
- W4386454484 hasPrimaryLocation W43864544841 @default.
- W4386454484 hasRelatedWork W1971316257 @default.
- W4386454484 hasRelatedWork W2008956692 @default.
- W4386454484 hasRelatedWork W2015965544 @default.
- W4386454484 hasRelatedWork W2040892198 @default.
- W4386454484 hasRelatedWork W2091652137 @default.
- W4386454484 hasRelatedWork W2130400674 @default.
- W4386454484 hasRelatedWork W2984347838 @default.
- W4386454484 hasRelatedWork W3030033435 @default.
- W4386454484 hasRelatedWork W3197508002 @default.
- W4386454484 hasRelatedWork W4256489590 @default.
- W4386454484 hasVolume "13" @default.
- W4386454484 isParatext "false" @default.
- W4386454484 isRetracted "false" @default.
- W4386454484 workType "article" @default.